These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 3863996)

  • 1. [Therapeutic effect of ofloxacin (DL 8280) on pulmonary tuberculosis. (Report of a one year-administration study on sixteen treatment-failure patients)].
    Tsukamura M; Nakamura E; Yoshii S; Yanase M; Yasuda Y; Amano H
    Kekkaku; 1985 Jun; 60(6):365-9. PubMed ID: 3863996
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of ofloxacin on 'treatment-failure' pulmonary tuberculosis].
    Tsunekawa H; Miyachi T; Nakamura E; Tsukamura M; Amano H
    Kekkaku; 1987 Sep; 62(9):435-9. PubMed ID: 3480971
    [No Abstract]   [Full Text] [Related]  

  • 3. [Trial of clinical administration of a new antibacterial substance DL 8280 in pulmonary tuberculosis].
    Tsukamura M; Yanase M
    Kekkaku; 1984 Sep; 59(9):477-81. PubMed ID: 6595460
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lung infections due to Mycobacterium fortuitum and Mycobacterium chelonae. Reports of nine cases of M. fortuitum infection and four cases of M. chelonae infection].
    Tsukamura M; Kita N; Shimoide H; Yoshimoto K; Wada T; Mitani Y
    Kekkaku; 1985 Aug; 60(8):429-34. PubMed ID: 3865015
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic effect of ofloxacin on mice challenged by ofloxacin-resistant Mycobacterium bovis strains].
    Tsukamura M
    Kekkaku; 1987 Apr; 62(4):235-8. PubMed ID: 3306084
    [No Abstract]   [Full Text] [Related]  

  • 6. [Case report on the effectiveness of ofloxacin (Tarivid) in large cavernous lung tuberculosis].
    Schmücker P; Cassier C; Koch G
    Prax Klin Pneumol; 1987 Aug; 41(8):306-7. PubMed ID: 3477790
    [No Abstract]   [Full Text] [Related]  

  • 7. [Laboratory and clinical study of ofloxacin in the treatment of bacterial prostatitis].
    Suzuki K; Tamai H; Naide Y; Ando K; Moriguchi R
    Hinyokika Kiyo; 1984 Oct; 30(10):1505-18. PubMed ID: 6596877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anti-bacterial effect of ofloxacin--in vitro and in vivo results].
    Altay G; Tulunay C
    Mikrobiyol Bul; 1985 Oct; 19(4):183-9. PubMed ID: 3868736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary disease due to Mycobacterium xenopi. Report of two cases.
    Bogaerts Y; Elinck W; van Renterghem D; Pauwels R; van der Straeten M
    Eur J Respir Dis; 1982 Jul; 63(4):298-304. PubMed ID: 7117427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary infection caused by Mycobacterium szulgai: a case report].
    Ikeue T; Watanabe S; Sugita T; Horikawa S; Suzuki Y; Nishiyama H; Maekawa N
    Kekkaku; 2002 May; 77(5):427-31. PubMed ID: 12073621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rifampicin in the treatment of drug-resistant tuberculosis. A report on 13 patients with pulmonary and one patient with renal disease.
    Engbaek HC; Vergmann B
    Scand J Respir Dis; 1970; 51(1):11-27. PubMed ID: 5456856
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical observation on treatment of retreated positive tubercle bacillus pneumoconio-tuberculosis with levofloxacin].
    Li JH; Wang YZ; Zhang HJ
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2004 Oct; 22(5):397-8. PubMed ID: 15555326
    [No Abstract]   [Full Text] [Related]  

  • 13. [The bacteriology of tuberculosis and non-tuberculosis mycobacterial infections].
    Wyplosz B; Truffot-Pernot C; Robert J; Jarlier V; Grosset J
    Rev Mal Respir; 1997 Dec; 14 Suppl 5():S33-48. PubMed ID: 9496590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Comparative studies of DL-8280 and pipemidic acid in complicated urinary tract infections by double-blind method].
    Kishi H; Nito H; Saito I; Nishimura Y; Niijima T; Ohmori H; Tanaka H; Fujita Y; Deguchi K; Ogawa N
    Hinyokika Kiyo; 1984 Sep; 30(9):1307-55. PubMed ID: 6395684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Achievement of sputum culture negative conversion by minocycline in a case with extensively drug-resistant pulmonary tuberculosis].
    Kawada H; Yamazato M; Shinozawa Y; Suzuki K; Otani S; Ouchi M; Miyairi M
    Kekkaku; 2008 Nov; 83(11):725-8. PubMed ID: 19086436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A case of pulmonary infection caused by Mycobacterium szulgai].
    Haranaga S; Sato Y; Tohyama M; Toyama M; Ishimine T; Miyara T; Shinzato T; Higa F; Tateyama M; Saito A
    Kekkaku; 2002 May; 77(5):421-5. PubMed ID: 12073620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Isolation of atypical Mycobacteria from patients with pulmonary tuberculosis on the selected Polish territories during the years 1970-1974].
    Zbikowski H
    Pneumonol Pol; 1980 Jun; 48(6):352-6. PubMed ID: 7402946
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinicopathological study of cases with Mycobacterium szulgai infection].
    Iwanaga T; Kishikawa R; Ikeda T; Hirose T; Tsurutani H; Yoshida S
    Kekkaku; 1998 Oct; 73(10):579-84. PubMed ID: 9844345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atypical pulmonary mycobacterioses. Epidemiology, diagnosis, and treatment.
    O'Brien RJ
    J Med Assoc Ga; 1986 Jan; 75(1):35-9. PubMed ID: 3950523
    [No Abstract]   [Full Text] [Related]  

  • 20. [Diagnosis of tuberculosis].
    Rüsch-Gerdes S
    Internist (Berl); 1995 Oct; 36(10):957-60. PubMed ID: 7499071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.